Cover Image
Market Research Report

Middle East and Africa Cell-based Assays Market: Industry Trends and Forecast to 2026

Published by Data Bridge Market Research Private Limited Product code 913488
Published Content info 80 Pages
Delivery time: 1-2 business days
Price
Back to Top
Middle East and Africa Cell-based Assays Market: Industry Trends and Forecast to 2026
Published: October 1, 2019 Content info: 80 Pages
Description

Middle East and Africa cell based assays market is projected to register a substantial CAGR in the forecast period 2019 to 2026. The new market report contains data for historic year 2017, the base year of calculation is 2018 and the forecast period is 2019 to 2026.

Market Segmentation:

By Type (Cell Viability Assay, Cytotoxicity Assay, Cell Death Assay, Cell Proliferation Assay, Others), Product & Services (Consumables, Services, Instruments and Software), Technology (Flow Cytometry, High Throughput Screening, High Content Screening, Label Free Detection), Application (Drug Discovery, Basic Research, Others), End User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Academic & Research Institutions, Government Organizations, Others), Distribution Channel (Direct, Indirect), Country (South Africa, Rest of Middle East and Africa)

Some of the major factors contributing to the growth of the market:

  • Rising demands for novel small drug and major therapeutics in MEA regions
  • Government funding in research and development areas for major diseases in MEA regions
  • Increasing incidence of Cancer, Rheumatoid arthritis and many other chronic diseases.

Key Market Players:

The key market players for Middle East and Africa cell based assays market are listed below:

  • GENERAL ELECTRIC
  • Danaher
  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • PerkinElmer Inc.
  • Bio-Rad Laboratories, Inc.
  • ATCC
  • Aurelia Bioscience Ltd
  • BD
  • BioAgilytix Labs
  • BioVision Inc.
  • Cell Signaling Technology, Inc
  • Cisbio
  • Enzo Biochem Inc
  • Eurofins Scientific
  • LakePharma, Inc
  • Lonza
  • Miltenyi Biotec
  • XenoDiagnostics, LLC
Table of Contents

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. OVERVIEW OF MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET
  • 1.4. LIMITATIONS
  • 1.5. MARKETS COVERED

2. MARKET SEGMENTATION

  • 2.1. MARKETS COVERED
  • 2.2. MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET: GEOGRAPHICAL SCOPE
  • 2.3. YEARS CONSIDERED FOR THE STUDY
  • 2.4. CURRENCY AND PRICING
  • 2.5. DBMR TRIPOD DATA VALIDATION MODEL
  • 2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
  • 2.7. DBMR MARKET POSITION GRID (ON THE BASIS OF PRODUCTS)
  • 2.8. DBMR MARKET POSITION GRID
  • 2.9. DBMR VENDOR SHARE ANALYSIS
  • 2.10. MULTIVARIATE MODELING
  • 2.11. PRODUCTS LIFELINE CURVE
  • 2.12. SECONDARY SOURCES
  • 2.13. ASSUMPTIONS

3. MARKET OVERVIEW

  • 3.1. DRIVERS
    • 3.1.1. INCREASING INCIDENCE OF CHRONIC DISEASES
    • 3.1.2. RISING DEMANDS FOR NOVEL SMALL MOLECULES, BIO-THERAPEUTIC AND CELL BASED THERAPIES
    • 3.1.3. INCREASE IN RESEARCH AND DEVELOPMENT EXPENDITURE
  • 3.2. RESTRAINT
    • 3.2.1. STRINGENT REGULATORY REQUIREMENTS
    • 3.2.2. HIGH COST OF INSTRUMENTATION
  • 3.3. OPPORTUNITIES
    • 3.3.1. TECHNOLOGICAL ADVANCEMENTS
    • 3.3.2. STRATEGIC INITIATIVE BY THE MARKET PLAYERS
  • 3.4. CHALLENGES
    • 3.4.1. CHALLENGING ANALYSIS PROCEDURE

4. EXECUTIVE SUMMARY

5. PREMIUM INSIGHTS

6. MIDDLE EAST AND AFRICA CELL-BASED ASSAYS MARKET, BY TYPE

  • 6.1. OVERVIEW
  • 6.2. CELL VIABILITY ASSAY
  • 6.3. CYTOTOXICITY ASSAY
  • 6.4. CELL PROLIFERATION ASSAY
  • 6.5. CELL DEATH ASSAY
  • 6.6. OTHERS

7. MIDDLE EAST AND AFRICA CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICES

  • 7.1. OVERVIEW
  • 7.2. CONSUMABLES
    • 7.2.1. ASSAY KITS
    • 7.2.2. CELL LINES
      • 7.2.2.1. PRIMARY CELL LINES
      • 7.2.2.2. STEM CELL LINES
      • 7.2.2.3. IMMORTALIZED CELL LINES
    • 7.2.3. REAGENTS
    • 7.2.4. MICROPLATES
  • 7.3. SERVICES
  • 7.4. INSTRUMENTS AND SOFTWARE

8. MIDDLE EAST AND AFRICA CELL-BASED ASSAYS MARKET, BY TECHNOLOGY

  • 8.1. OVERVIEW
  • 8.2. HIGH THROUGHPUT SCREENING
  • 8.3. FLOW CYTOMETRY
  • 8.4. HIGH CONTENT SCREENING
  • 8.5. LABEL FREE DETECTION

9. MIDDLE EAST AND AFRICA CELL-BASED ASSAYS MARKET, BY APPLICATION

  • 9.1. OVERVIEW
  • 9.2. DRUG DISCOVERY
    • 9.2.1. PREDICTIVE TOXICOLOGY
    • 9.2.2. PHARMACODYNAMIC STUDIES
    • 9.2.3. ADME RESEARCH
  • 9.3. BASIC RESEARCH
  • 9.4. OTHERS

10. MIDDLE EAST AND AFRICA CELL-BASED ASSAYS MARKET, BY END USER

  • 10.1. OVERVIEW
  • 10.2. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  • 10.3. CONTRACT RESEARCH ORGANIZATIONS
  • 10.4. ACADEMIC & RESEARCH INSTITUTIONS
  • 10.5. GOVERNMENT ORGANIZATIONS
  • 10.6. OTHERS

11. MIDDLE EAST AND AFRICA CELL-BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL

  • 11.1. OVERVIEW
  • 11.2. DIRECT
  • 11.3. INDIRECT

12. MIDDLE EAST AND AFRICA CELL BASED ASSAY MARKET, BY GEOGRAPHY

  • 12.1. MIDDLE EAST AND AFRICA
    • 12.1.1. SOUTH AFRICA
    • 12.1.2. REST OF MIDDLE EAST AND AFRICA
    • 12.1.3. EGYPT
    • 12.1.4. SAUDI ARAIA
    • 12.1.5. UNITED ARAB EMIRATES
    • 12.1.6. ISRAEL

13. MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET FOR PRODUCTS, COMPANY LANDSCAPE

  • 13.1. COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA

14. MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET FOR SERVICES, COMPANY LANDSCAPE

  • 14.1. COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA

15. COMPANY PROFILE

  • 15.1. GENERAL ELECTRIC
    • 15.1.1. COMPANY SNAPSHOT
    • 15.1.2. REVENUE ANALYSIS
    • 15.1.3. COMPANY SHARE ANALYSIS
    • 15.1.4. PRODUCT PORTFOLIO
    • 15.1.5. RECENT DEVELOPMENTS

  • 15.2. DANAHER
    • 15.2.1. COMPANY SNAPSHOT
    • 15.2.2. REVENUE ANALYSIS
    • 15.2.3. COMPANY SHARE ANALYSIS
    • 15.2.4. PRODUCT PORTFOLIO
    • 15.2.5. RECENT DEVELOPMENT
  • 15.3. AGILENT TECHNOLOGIES, INC.
      • 15.3.1.1. COMPANY SNAPSHOT
    • 15.3.2. REVENUE ANALYSIS
    • 15.3.3. COMPANY SHARE ANALYSIS
    • 15.3.4. PRODUCT PORTFOLIO
    • 15.3.5. RECENT DEVELOPMENTS
  • 15.4. THERMO FISHER SCIENTIFIC INC
    • 15.4.1. COMPANY SNAPSHOT
    • 15.4.2. REVENUE ANALYSIS
    • 15.4.3. COMPANY SHARE ANALYSIS
    • 15.4.4. PRODUCT PORTFOLIO
    • 15.4.5. RECENT DEVELOPMENT
  • 15.5. MERCK KGAA
    • 15.5.1. COMPANY SNAPSHOT
    • 15.5.2. REVENUE ANALYSIS
    • 15.5.3. PRODUCT PORTFOLIO
    • 15.5.4. RECENT DEVELOPMENT
  • 15.6. PERKINELMER INC, INC.
    • 15.6.1. COMPANY SNAPSHOT
    • 15.6.2. REVENUE ANALYSIS
    • 15.6.3. PRODUCT PORTFOLIO
    • 15.6.4. RECENT DEVELOPMENT
  • 15.7. BIO-RAD LABORATORIES, INC.
    • 15.7.1. COMPANY SNAPSHOT
    • 15.7.2. REVENUE ANALYSIS
    • 15.7.3. PRODUCT PORTFOLIO
    • 15.7.4. RECENT DEVELOPMENTS
  • 15.8. ATCC
    • 15.8.1. COMPANY SNAPSHOT
    • 15.8.2. PRODUCT PORTFOLIO
    • 15.8.3. RECENT DEVELOPMENT
  • 15.9. AURELIA BIOSCIENCE LTD.
    • 15.9.1. COMPANY SNAPSHOT
    • 15.9.2. SERVICE PORTFOLIO
    • 15.9.3. RECENT DEVELOPMENT
  • 15.10. BD
    • 15.10.1. COMPANY SNAPSHOT
    • 15.10.2. REVENUE ANALYSIS
    • 15.10.3. PRODUCT PORTFOLIO
    • 15.10.4. RECENT DEVELOPMENTS
  • 15.11. BIOAGILYTIX LABS
    • 15.11.1. COMPANY SNAPSHOT
    • 15.11.2. SERVICE PORTFOLIO
    • 15.11.3. RECENT DEVELOPMENTS
  • 15.12. BIOVISION INC.
    • 15.12.1. COMPANY SNAPSHOT
    • 15.12.2. PRODUCT PORTFOLIO
    • 15.12.3. RECENT DEVELOPMENT
  • 15.13. CELL SIGNALING TECHNOLOGY, INC.
    • 15.13.1. COMPANY SNAPSHOT
    • 15.13.2. PRODUCT PORTFOLIO
    • 15.13.3. RECENT DEVELOPMENT
  • 15.14. CISBIO
    • 15.14.1. COMPANY SNAPSHOT
    • 15.14.2. PRODUCT PORTFOLIO
    • 15.14.3. RECENT DEVELOPMENT
  • 15.15. ENZO BIOCHEM INC.
    • 15.15.1. COMPANY SNAPSHOT
    • 15.15.2. REVENUE ANALYSIS
    • 15.15.3. PRODUCT PORTFOLIO
    • 15.15.4. RECENT DEVELOPMENT
  • 15.16. EUROFINS SCIENTIFIC
    • 15.16.1. COMPANY SNAPSHOT
    • 15.16.2. REVENUE ANALYSIS
    • 15.16.3. PRODUCT AND SERVICE PORTFOLIO
    • 15.16.4. RECENT DEVELOPMENTS
  • 15.17. LAKEPHARMA, INC.
    • 15.17.1. COMPANY SNAPSHOT
    • 15.17.2. SERVICE PORTFOLIO
    • 15.17.3. RECENT DEVELOPMENT
  • 15.18. LONZA
    • 15.18.1. COMPANY SNAPSHOT
    • 15.18.2. REVENUE ANALYSIS
    • 15.18.3. SERVICE PORTFOLIO
    • 15.18.4. RECENT DEVELOPMENT
  • 15.19. MILTENYI BIOTEC
    • 15.19.1. COMPANY SNAPSHOT
      • 15.19.2.2. PRODUCT PORTFOLIO
    • 15.19.3. RECENT DEVELOPMENT
  • 15.20. XENO DIAGNOSTICS, LLC.
    • 15.20.1. COMPANY SNAPSHOT
    • 15.20.2. PRODUCT PORTFOLIO
    • 15.20.3. RECENT DEVELOPMENT

16. QUESTIONNAIRE

17. RELATED REPORTS

LIST OF TABLES

  • TABLE 1 AGEING WORLD POPULATION (IN MILLIONS)
  • TABLE 2 TABLE REGIONS BY DIABETES PREVALENCE (%) IN ELDERLY POPULATION IN 2017 AND 2045 (IN MILLIONS)
  • TABLE 3 TOP 20 PHARMA COMPANIES BY SIZE OF PIPELINE
  • TABLE 4 MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 5 MIDDLE EAST AND AFRICA CELL VIABILITY ASSAY IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 6 MIDDLE EAST AND AFRICA CYTOTOXICITY ASSAY IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 7 MIDDLE EAST AND AFRICA CELL PROLIFERATION ASSAY IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 8 MIDDLE EAST AND AFRICA CELL DEATH ASSAY IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 9 MIDDLE EAST AND AFRICA OTHERS IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 10 MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 11 MIDDLE EAST AND AFRICA CONSUMABLES IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 12 MIDDLE EAST AND AFRICA CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 13 MIDDLE EAST AND AFRICA CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 14 MIDDLE EAST AND AFRICA SERVICES IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 15 MIDDLE EAST AND AFRICA INSTRUMENTS AND SOFTWARE IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 16 MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
  • TABLE 17 MIDDLE EAST AND AFRICA HIGH THROUGHPUT SCREENING IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 18 MIDDLE EAST AND AFRICA FLOW CYTOMETRY IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 19 MIDDLE EAST AND AFRICA HIGH CONTENT SCREENING IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 20 MIDDLE EAST AND AFRICA LABEL FREE DETECTION IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 21 MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 22 MIDDLE EAST AND AFRICA DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 23 MIDDLE EAST AND AFRICA DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 24 MIDDLE EAST AND AFRICA BASIC RESEARCH IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 25 MIDDLE EAST AND AFRICA OTHERS IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 26 MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 27 MIDDLE EAST AND AFRICA PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 28 MIDDLE EAST AND AFRICA CONTRACT RESEARCH ORGANIZATIONS IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 29 MIDDLE EAST AND AFRICA ACADEMIC & RESEARCH INSTITUTIONS IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 30 MIDDLE EAST AND AFRICA GOVERNMENT ORGANIZATIONS IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 31 MIDDLE EAST AND AFRICA OTHERS IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 32 MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 33 MIDDLE EAST AND AFRICA DIRECT IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 34 MIDDLE EAST AND AFRICA INDIRECT IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
  • TABLE 35 MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET, BY COUNTRY, 2017-2026 (USD MILLION)
  • TABLE 36 MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 37 MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 38 MIDDLE EAST AND AFRICA CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 39 MIDDLE EAST AND AFRICA CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 40 MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
  • TABLE 41 MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 42 MIDDLE EAST AND AFRICA DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 43 MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 44 MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 45 SOUTH AFRICA CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
  • TABLE 46 SOUTH AFRICA CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 47 SOUTH AFRICA CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 48 SOUTH AFRICA CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
  • TABLE 49 SOUTH AFRICA CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
  • TABLE 50 SOUTH AFRICA CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 51 SOUTH AFRICA DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
  • TABLE 52 SOUTH AFRICA CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
  • TABLE 53 SOUTH AFRICA CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
  • TABLE 54 REST OF MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1 MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET
  • FIGURE 2 MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET: DATA VALIDATION MODEL
  • FIGURE 3 MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET: DROC ANALYSIS
  • FIGURE 4 MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET: MIDDLE EAST AND AFRICA VS REGIONAL ANALYSIS
  • FIGURE 5 MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET: COMPANY RESEARCH ANALYSIS
  • FIGURE 6 MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET: INTERVIEW DEMOGRAPHICS
  • FIGURE 7 MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET: DBMR MARKET POSITION GRID
  • FIGURE 8 MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET: DBMR MARKET POSITION GRID (ON THE BASIS OF SERVICES)
  • FIGURE 9 MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET: DBMR VENDOR SHARE ANALYSIS (ON THE BASIS OF PRODUCTS)
  • FIGURE 10 MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET: DBMR VENDOR SHARE ANALYSIS (ON THE BASIS OF SERVICES)
  • FIGURE 11 DRIVERS, RESTRAINT, OPPORTUNITIES AND CHALLENGES OF THE MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET
  • FIGURE 12 WORLDWIDE BIOPHARMA COMPANIES R&D EXPENDITURE (IN MILLION U.S. DOLLARS)
  • FIGURE 13 MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET: SEGMENTATION
  • FIGURE 14 INCREASING INCIDENCE OF CHRONIC DISEASES AND RISING DEMANDS FOR NOVEL SMALL MOLECULES, BIO-THERAPEUTIC AND CELL BASED THERAPIES ARE EXPECTED TO DRIVE THE MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET IN THE FORECAST PERIOD OF 2019 TO 2026
  • FIGURE 15 CELL VIABILITY ASSAY IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET IN THE FORECAST PERIOD OF 2019 TO 2026
  • FIGURE 16 MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET DOMINATED BY CELL VIABILITY ASSAY (2018)
  • FIGURE 17 MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET: BY TYPE, 2018
  • FIGURE 18 MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET: BY TYPE, CAGR (2019-2026)
  • FIGURE 19 MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET: BY TYPE, LIFELINE CURVE
  • FIGURE 20 MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET DOMINATED BY CONSUMABLES (2018)
  • FIGURE 21 MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET: BY PRODUCT & SERVICES, 2018
  • FIGURE 22 MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET: BY PRODUCT & SERVICES, CAGR (2019-2026)
  • FIGURE 23 MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET: BY PRODUCT & SERVICES, LIFELINE CURVE
  • FIGURE 24 MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET DOMINATED BY HIGH THROUGHPUT SCREENING (2018)
  • FIGURE 25 MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET: BY TECHNOLOGY, 2018
  • FIGURE 26 MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET: BY TECHNOLOGY, CAGR (2019-2026)
  • FIGURE 27 MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET: BY TECHNOLOGY, LIFELINE CURVE
  • FIGURE 28 MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET DOMINATED BY DRUG DISCOVERY (2018)
  • FIGURE 29 MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET: BY APPLICATION, 2018
  • FIGURE 30 MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET: BY APPLICATION, CAGR (2019-2026)
  • FIGURE 31 MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET: BY APPLICATION, LIFELINE CURVE
  • FIGURE 32 MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET DOMINATED BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES (2018)
  • FIGURE 33 MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET: BY END USER, 2018
  • FIGURE 34 MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET: BY END USER, CAGR (2019-2026)
  • FIGURE 35 MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET: BY END USER, LIFELINE CURVE
  • FIGURE 36 MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET DOMINATED BY DIRECT (2018)
  • FIGURE 37 MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET: BY DISTRIBUTION CHANNEL, 2018
  • FIGURE 38 MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2019-2026)
  • FIGURE 39 MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
  • FIGURE 40 MIDDLE EAST AND AFRICA CELL BASED ASSAY MARKET: SNAPSHOT (2018)
  • FIGURE 41 MIDDLE EAST AND AFRICA CELL BASED ASSAY MARKET: BY COUNTRY (2018)
  • FIGURE 42 MIDDLE EAST AND AFRICA CELL BASED ASSAY MARKET: BY COUNTRY (2019 & 2026)
  • FIGURE 43 MIDDLE EAST AND AFRICA CELL BASED ASSAY MARKET: BY COUNTRY (2018 & 2026)
  • FIGURE 44 MIDDLE EAST AND AFRICA CELL BASED ASSAY MARKET: BY TYPE (2019-2026)
  • FIGURE 45 MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET: COMPANY SHARE 2018 (%)
  • FIGURE 46 MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET: COMPANY SHARE 2018 (%)
Back to Top